ELRANATAMAB for Plasma cell myeloma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 518 adverse event reports in the FDA FAERS database where ELRANATAMAB was used for Plasma cell myeloma.

Most Reported Side Effects for ELRANATAMAB

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	131	17.3%	25	76
Immune effector cell-associated neurotoxicity syndrome	44	5.8%	15	29
Death	42	5.5%	42	3
Pyrexia	42	5.5%	7	24
Pneumonia	40	5.3%	19	30
Cytomegalovirus infection	34	4.5%	9	24
Neutropenia	30	4.0%	6	14
Covid-19	29	3.8%	10	20
Infection	28	3.7%	10	15
Cytomegalovirus infection reactivation	24	3.2%	5	11
Plasma cell myeloma	24	3.2%	17	11
Hypogammaglobulinaemia	22	2.9%	3	11
Diarrhoea	21	2.8%	2	15
Neoplasm progression	20	2.6%	15	4
Platelet count decreased	18	2.4%	6	8